Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, $0.01 Par Value
-
Shares outstanding
-
22.7M
-
Number of holders
-
282
-
Total 13F shares, excl. options
-
21.2M
-
Shares change
-
+51.4K
-
Total reported value, excl. options
-
$1.76B
-
Value change
-
+$3.91M
-
Number of buys
-
139
-
Number of sells
-
-126
-
Price
-
$83.05
Significant Holders of LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) as of Q2 2025
313 filings reported holding LMAT - LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value as of Q2 2025.
LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) has 282 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.2M shares
of 22.7M outstanding shares and own 93.35% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (3.18M shares), Conestoga Capital Advisors, LLC (1.6M shares), VANGUARD GROUP INC (1.6M shares), Copeland Capital Management, LLC (990K shares), GENEVA CAPITAL MANAGEMENT LLC (915K shares), STATE STREET CORP (810K shares), CONGRESS ASSET MANAGEMENT CO (674K shares), FIRST TRUST ADVISORS LP (612K shares), GEODE CAPITAL MANAGEMENT, LLC (520K shares), and Ranger Investment Management, L.P. (514K shares).
This table shows the top 282 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.